Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study-Reference-Cited by-同舟云学术

Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study

Published:2009-01 Issue:1 Volume:41 Page:10-13
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Tabarsi Payam,Baghaei Parvaneh,Jalali Sara,Farnia Parisa,Chitsaz Ehsan,Mirsaeidi Mehdi,Kazempour Mehdi,Mansouri Davoud,Masjedi Mohammad R.,Velayati Ali A.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365540802298079

Reference22 articles.

1. Programmes and principles in treatment of multidrug-resistant tuberculosis

2. Multidrug-resistant tuberculosis

3. Multidrug-Resistant Tuberculosis in Patients without HIV Infection

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study;Medical Science Monitor;2017-05-18

2. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis;European Respiratory Journal;2017-03

3. Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis;American Journal of Therapeutics;2016-03

4. Adverse Effects of Multidrug-Resistant Tuberculosis Treatment With a Standardized Regimen: A Report From Iran;American Journal of Therapeutics;2011-03

5. Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis;Current Clinical Pharmacology;2010-05-01